Panel Discussion: What Evidence Gives Us Confidence That a Model Will Translate?
1:50 pm - Thursday 3rd December 2026
- How can clinical observations and reverse translational insights be used to improve future model development and regulatory confidence?
- What role should patient-derived and human-relevant tumour models play in identifying novel targets and improving candidate selection?
- Which biological, translational, or clinical endpoints provide the strongest evidence that a programme is ready for progression?
- Audience Q&As
